These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 231013)
21. Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonist dosing in combination with gestagen-induced bleeding. Lemay A; Faure N; Labrie F; Fazekas AT Fertil Steril; 1985 Jun; 43(6):868-77. PubMed ID: 3158551 [TBL] [Abstract][Full Text] [Related]
22. Regression of uterine leiomyomata in response to the antiprogesterone RU 486. Murphy AA; Kettel LM; Morales AJ; Roberts VJ; Yen SS J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797 [TBL] [Abstract][Full Text] [Related]
23. [Clinical significance of analysis of estrogen and progesterone receptors in human uterine tissues]. Maleeva A; Milkov V Akush Ginekol (Mosk); 1991 May; (5):55-7. PubMed ID: 1897675 [TBL] [Abstract][Full Text] [Related]
24. [Estrogen and progesterone receptors in endometrial carcinoma during high-dose progestogen (Depo-Provera) therapy]. Thurzó L; Sas M; Falkay G Orv Hetil; 1986 Oct; 127(43):2613-6. PubMed ID: 2947029 [No Abstract] [Full Text] [Related]
25. Morphology of human uterine cancer in nude mice. Effects of hormone and antihormone treatment. Zaino RJ; Satyaswaroop PG; Mortel R Arch Pathol Lab Med; 1984 Jul; 108(7):571-8. PubMed ID: 6547322 [TBL] [Abstract][Full Text] [Related]
26. Estrogen and progestogen receptor levels in different types of mid-secretory endometrium. Tamaya T; Murakami T; Ohono Y; Yamada T; Wada K; Okada H Asia Oceania J Obstet Gynaecol; 1983 Sep; 9(3):353-8. PubMed ID: 6416240 [No Abstract] [Full Text] [Related]
27. The possible mechanisms of action of progestins on endometrial adenocarcinoma. Anderson DG Am J Obstet Gynecol; 1972 May; 113(2):195-211. PubMed ID: 4112650 [TBL] [Abstract][Full Text] [Related]
28. Steroidal regulation of endometriosis tissue: lack of induction of 17 beta-hydroxysteroid dehydrogenase activity by progesterone, medroxyprogesterone acetate, or danazol. Vierikko P; Kauppila A; Rönnberg L; Vihko R Fertil Steril; 1985 Feb; 43(2):218-24. PubMed ID: 2981748 [TBL] [Abstract][Full Text] [Related]
29. [Value of steroid receptors assessment in atypical endometrial hyperplasia]. Teleman S; Mihailovici MS Rev Med Chir Soc Med Nat Iasi; 2003; 107(4):813-6. PubMed ID: 14756025 [TBL] [Abstract][Full Text] [Related]
30. Steroid receptors in normal, hyperplastic and malignant human endometria. Vihko R; Jänne O; Kauppila A Ann Clin Res; 1980 Oct; 12(5):208-15. PubMed ID: 7015983 [TBL] [Abstract][Full Text] [Related]
31. [Response of estrogen and progesterone receptors to treatment with large doses of progestogen (depo-provera) in endometrial cancer]. Thurzó L Zentralbl Gynakol; 1990; 112(17):1111-5. PubMed ID: 2148245 [TBL] [Abstract][Full Text] [Related]
32. Plasma sex steroid and gonadotropin levels in control and silastic vaginal medroxyprogesterone acetate-impregnated ring cycles. Vermeulen A; Dhondt M; Thiery M; Vandekerckhove D Fertil Steril; 1976 Jul; 27(7):773-9. PubMed ID: 950046 [TBL] [Abstract][Full Text] [Related]
33. [Cytoplasmic estrogen and progestin receptors in uterine myomatous tissue and serum estradiol and progesterone levels in women with uterine myoma]. Chen GA Zhonghua Fu Chan Ke Za Zhi; 1984 Apr; 19(2):88-92. PubMed ID: 6468092 [No Abstract] [Full Text] [Related]
34. Physiologic changes in binding and metabolism of estradiol and progesterone in human endometrium during the menstrual cycle. Tseng L Obstet Gynecol Annu; 1979; 8():1-17. PubMed ID: 390448 [No Abstract] [Full Text] [Related]
35. [Changes of sex steroid hormone receptors in rat uterine cytosol during experimental induction of endometrial carcinoma (author's transl)]. Nagasaka T Acta Obstet Gynaecol Jpn; 1981 Jun; 33(6):757-66. PubMed ID: 6454322 [TBL] [Abstract][Full Text] [Related]
36. Estradiol and progesterone receptors in normal and neoplastic endometrium: correlations between receptors, histopathological examinations and clinical responses under progestin therapy. Martin PM; Rolland PH; Gammerre M; Serment H; Toga M Int J Cancer; 1979 Mar; 23(3):321-9. PubMed ID: 437916 [No Abstract] [Full Text] [Related]
37. Effects of luteal estradiol on the secretory transformation of human endometrium and plasma gonadotropins. de Ziegler D; Bergeron C; Cornel C; Medalie DA; Massai MR; Milgrom E; Frydman R; Bouchard P J Clin Endocrinol Metab; 1992 Feb; 74(2):322-31. PubMed ID: 1730810 [TBL] [Abstract][Full Text] [Related]
38. Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium. Ehrlich CE; Young PC; Stehman FB; Sutton GP; Alford WM Am J Obstet Gynecol; 1988 Apr; 158(4):796-807. PubMed ID: 2966586 [TBL] [Abstract][Full Text] [Related]
39. Endometrial carcinoma: steroid receptors and response to medroxyprogesterone acetate. Quinn MA; Cauchi M; Fortune D Gynecol Oncol; 1985 Jul; 21(3):314-9. PubMed ID: 3159630 [TBL] [Abstract][Full Text] [Related]
40. Heterogeneity and progesterone-receptor distribution in endometrial adenocarcinoma. Mortel R; Zaino R; Satyaswaroop PG Cancer; 1984 Jan; 53(1):113-6. PubMed ID: 6689993 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]